Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Clinical results from international comparative study of olanzapine and haloperidol

April 24, 1997

Eletriptan enters phase III trials

April 24, 1997

Yamasa describes cognition-enhancing agents

April 24, 1997

Arzneimittelwerk describes new anticonvulsants

April 24, 1997

Grape seed proanthocyanidins compared to other antioxidants in vitro and in vivo

April 24, 1997

Canadian clearance for Naropin

April 23, 1997

Positive clinical results for mitoxantrone in multiple sclerosis

April 23, 1997

Piracetam as an adjuvant to language therapy for aphasia

April 23, 1997

Novel 5-HT uptake inhibitors from Bristol-Myers Squibb

April 23, 1997

AutoImmune freezes development of Myloral

April 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...